R&D
How AI simulation could help de-risk obesity and cardiometab...
AI life sciences models allow researchers to explore different patient populations, protocols, and development strategies before a study starts.
Sales & Marketing
Sponsored
Accelerating growth through strategic investment in healthca...
CEVA FORPATIENTS at Rockingham, UK will offer the healthcare supply chain a new, sustainably designed multi-user site.
R&D
Alzheimer's research is moving toward more selective targets
As we mark World Alzheimer’s Day, it is worth reflecting on the progress made in recent years.
Market Access
How new PBM transparency rules will alter drug pricing
The complex drug pricing ecosystem means all stakeholders are scrambling to understand how the new regulations and PBMs’ adjustments will impact them.
Market Access
Sponsored
From first approval to lasting value: What sets successful e...
Approval may validate the science, but it does not secure commercial success. That outcome is determined by the decisions made before launch.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
